Member Info for Shukan

So - Phase 1 pre clinical starting with Monkeys going into Phase 2 Human Trials

Within the presentation we have more detail on the CDX anti body within the chimeric mice model all tests were successful
I like the fact he mentions the antibodies were tested with existing treatments and will work hand in hand giving better outcomes for patients- P2

Hemogenyx Investival Conference Presentation November 19, 2019 - “noise on the ground” watch this space

https://www.youtube.com/watch?v=WK9FrOukj-w

Second Phase - meaning validation exciting times ahead

Your deluding yourself - sorry to say just like AW did

To oblivion- they have jumped ship

along those lines yes - Vlad disillusioned with London market and Peter did say he is open to discussion - the key obviously is what this "Global Pharma" are up to - surprised at no director buying down here at 1.8p on the bid.

"Global Pharma" have a gagging order in place I kid you not - he had a right b***ing last time out "end of May interview"
so do not expect anything until they are ready

I have had a long and meaningful conversation with the bod on this matter , a mistake was made I’ve excepted this and we move on.
I continue to hold

RNS - narrative continues with Global Pharma

Received apology

Let the games begin !

I am now blocked on his twitter feed - so the CEO blocks shareholders asking questions about the performance of his company since IPO

Direct your anger to Dr Sandler - for within the Zak interview end of May he pointed out that there was a deal soon or very soon . Many of us have already made our views known to the Company

NO - 5th of October was the cut off date

THE term and conditions of the issue -

Warrants have EVERYTHING TO DO WITH IT !

Keep in mind the USA market - Vlad not happy with Current London market valuation the deal will be a game changer.

added another 80K of shares this morning very happy to hold.

HEMO will be a takeover target once that deal hits the market- London does not understand it USA does